Is Life Science Real Estate the new Core?

The life sciences and healthcare sector is currently one of the fastest growing sectors of the economy and the demand for real estate tailored to it is increasing, and not only due to the pandemic. What are the requirements and how do life sciences properties differ from others? Is this giving rise to a separate asset class that will enable targeted investments in this sector?

We cordially invite you to participate in our event on 18 November 2021 on the topic of life sciences real estate and to discuss these questions with proven experts.

Lisette van Doorn, CEO of ULI Europe, will give an introductory keynote speech in which she will present the results of the study "Understanding the Life Sciences sector. The Case for Real Estate Investment".

This will be followed by a German-language panel discussion in which we will explore the topic in more depth together with:

  • Martin Eberhardt FRICS, owner of AperDurus

  • Prof. Dr. Thomas Glatte, Director Real Estate at BASF

  • Fabian Raddatz, Managing Director, Labor Berlin

We look forward to welcoming you to our virtual event! Click here to register:

1 view0 comments

Recent Posts

See All

RICS Independent Review

The Governing Council of RICS has published the Independent Review by Alison Levitt QC into the events that took place following the commissioning of a Treasury Management audit in 2018 and has voted